from Reuters: Health News https://reut.rs/2EEGvZp
Thursday, February 28, 2019
Novavax shares plunge 65 percent as respiratory vaccine fails in late-stage trial
Novavax Inc shares crashed 65 percent on Thursday after data showed its vaccine failed to prevent RSV disease, a leading cause of respiratory infections in infants, missing the main goal of a late-stage study.
from Reuters: Health News https://reut.rs/2EEGvZp
from Reuters: Health News https://reut.rs/2EEGvZp
Subscribe to:
Post Comments (Atom)
-
(Reuters Health) - More than half of heart failure patients who visit the emergency room don't receive prompt follow-up care, and a Cana...
-
WEIGHT LOSS supplements could help overweight or obese patients with the diet plans. You could lose weight and avoid weight gain by adding...
-
A U.S. appeals court on Wednesday declined a request by Johnson & Johnson for an temporary restraining order blocking sales of generic v...
No comments:
Post a Comment